Literature DB >> 7762022

Transient forebrain ischemia protects against subsequent focal cerebral ischemia without changing cerebral perfusion.

K Matsushima1, A M Hakim.   

Abstract

BACKGROUND AND
PURPOSE: The possibility that the brain may be preconditioned to be more tolerant of ischemia is an important concept with important clinical implications. Exploring the concept offers the possibility of advancing our understanding of protective molecular responses in the brain. This article compares two preconditioning methods and explores the role that changes in regional cerebral blood flow (rCBF) may play in conferring ischemic protection.
METHODS: Temporary occlusion of the middle cerebral artery (MCA) using the thread model was preceded 4 days earlier by short-lasting focal or global ischemia or by sham surgery. rCBF was measured in the frontoparietal region of the ischemic hemisphere during all focal ischemia episodes. Four days after the second ischemic exposure, animals were killed, and the size of infarction was determined.
RESULTS: rCBF was significantly higher in the frontoparietal region during MCA occlusion when it was preceded by prior focal ischemia (36.8 +/- 7.6 mL x 100 g-1 at 30 minutes) compared with controls (24.7 +/- 4.0 mL x 100 g-1.min-1, P = .0008). Despite this, there was no significant difference in the resulting infarct volume. In contrast, when MCA occlusion was preceded by global ischemia, infarct volume was significantly reduced (68.1 +/- 30.9 mm3 in the controls versus 22.9 +/- 22.1 mm3 in the preconditioned group, P = .002) without significant change in rCBF.
CONCLUSIONS: Protection from ischemic injury requires specific conditions of prior exposure to ischemia. Improved perfusion would not seem to be a sufficient or necessary accompaniment to providing neuroprotection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762022     DOI: 10.1161/01.str.26.6.1047

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

1.  Strategies to defeat ketamine-induced neonatal brain injury.

Authors:  C P Turner; S Gutierrez; C Liu; L Miller; J Chou; B Finucane; A Carnes; J Kim; E Shing; T Haddad; A Phillips
Journal:  Neuroscience       Date:  2012-02-23       Impact factor: 3.590

Review 2.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

Review 3.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

Review 4.  Ischemic tolerance as an active and intrinsic neuroprotective mechanism.

Authors:  R Anne Stetler; Feng Zhang; Collin Liu; Jun Chen
Journal:  Handb Clin Neurol       Date:  2009

5.  Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.

Authors:  Ramiro Echeverry; Jialing Wu; Woldeab B Haile; Johanna Guzman; Manuel Yepes
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

6.  RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).

Authors:  Shimin Liu; Gehua Zhen; Bruno P Meloni; Kym Campbell; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2009-01-01

7.  Preconditioning the brain: moving on to the next frontier of neurotherapeutics.

Authors:  Sebastian Koch; Ralph L Sacco; Miguel A Perez-Pinzon
Journal:  Stroke       Date:  2012-03-29       Impact factor: 7.914

8.  Activation of the nuclear factor-kappaB is a key event in brain tolerance.

Authors:  N Blondeau; C Widmann; M Lazdunski; C Heurteaux
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

9.  3-Nitropropionic acid-induced ischemia tolerance in the rat brain is mediated by reduced metabolic activity and cerebral blood flow.

Authors:  Oliver Bracko; Valentina Di Pietro; Giacomo Lazzarino; Angela M Amorini; Barbara Tavazzi; Judith Artmann; Eric C Wong; Richard B Buxton; Michael Weller; Andreas R Luft; Susanne Wegener
Journal:  J Cereb Blood Flow Metab       Date:  2014-06-18       Impact factor: 6.200

10.  Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection.

Authors:  Aysan Durukan; Turgut Tatlisumak
Journal:  Exp Transl Stroke Med       Date:  2010-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.